Amanda L Amin1, Amanda L Kong. 1. Department of Surgery, Medical College of Wisconsin, Milwaukee 53226, USA.
Abstract
BACKGROUND: Tumor metastatic to the breast is uncommon, and a neuroendocrine tumor metastatic to the breast is even more unusual. The breast lesion can be the first manifestation of a nonmammary malignancy. METHODS: Metastatic neuroendocrine tumors to the breast have been described in the literature in case reports or very small case series. Because of the small number, current treatment recommendations are not well defined. We present a case report of a metastatic neuroendocrine tumor that first presented as a breast lesion on screening mammography. CONCLUSION: Accurate diagnosis is important for appropriate management, as the treatment for a breast primary neuroendocrine tumor is different than a neuroendocrine tumor metastatic to the breast.
BACKGROUND: Tumor metastatic to the breast is uncommon, and a neuroendocrine tumor metastatic to the breast is even more unusual. The breast lesion can be the first manifestation of a nonmammary malignancy. METHODS:Metastatic neuroendocrine tumors to the breast have been described in the literature in case reports or very small case series. Because of the small number, current treatment recommendations are not well defined. We present a case report of a metastatic neuroendocrine tumor that first presented as a breast lesion on screening mammography. CONCLUSION: Accurate diagnosis is important for appropriate management, as the treatment for a breast primary neuroendocrine tumor is different than a neuroendocrine tumor metastatic to the breast.
Authors: Joakim Crona; Dan Granberg; Olov Norlén; Fredrik Wärnberg; Peter Stålberg; Per Hellman; Peyman Björklund Journal: World J Surg Date: 2013-07 Impact factor: 3.352
Authors: Sara Tato-Varela; Rosa Albalat-Fernández; Sara Pabón-Fernández; Enrique Rodríguez Zarco; Manolo La Calle-Marcos Journal: Ecancermedicalscience Date: 2015-12-22